Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1498-1504

  Yu, De Chao ^a   Sakamoto, Gordon T ^a   Henderson, Daniel R ^a  

^a Calydon Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN;

ADENOVIRUS; ARTICLE; ENDOTHELIUM CELL; ENHANCER REGION; GENE SEQUENCE; HUMAN CELL; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROCESSING; RECEPTOR UPREGULATION; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

ADENOVIRIDAE; BASE SEQUENCE; ENHANCER ELEMENTS (GENETICS); GENE THERAPY; HUMANS; KALLIKREINS; MALE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0033119603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Clements, J. The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr. Rev., 10: 393-419, 1989.
2. Young, C., Andrews, P., and Tindall, D. Expression and androgenic regulation of human prostate-specific kallikreins. J. Androl., 16: 97-99, 1995.
3. Carbini, L., Scicli, G. A., and Carretero, O. A. The molecular biology of the kallikrein-kinin system: IV. The human kallikrein gene family and kallikrein substrate. J. Hypertens., 11: 893-898, 1993.
4. Riegman, P., Vlietstra, R., Suurmeuer, L., Cleutjens, C., and Trapman, J. Characterization of the human kallikrein locus. Genomics, 14: 6-11, 1992.
5. Morris, B. HGK-1: a kallikrein gene expressed in human prostate. Clin. Exp. Pharmacol. Physiol., 16: 345-351, 1989.
6. Schedlich, L., Bennetts, B., and Morris, B. Primary structure of a human glandular kallikrein gene. DNA, 6: 429-437, 1987.
7. Wang, M. C., Papsidero, L. D., Kuriyama, M., Valenzuela, L. A., Murphy, G. P., and Chu, T. M. Prostate antigen: a new potential marker for prostatic cancer. Prostate, 2: 89-96, 1981.
8. Catalona, W. Management of cancer of the prostate. N. Engl. J. Med., 331: 996-1004, 1994.
9. Saedi, M. S., Cass, M. M., Goel, A. S., Grauer, L., Hogan, K. L., Okaneya, T., Griffin, B. Y., Klee, G. G., Young, C. Y., and Tindall, D. J. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol. Cell. Endocrinol., 109: 237-241, 1995.
10. Tremblay, R., Deperthes, D., Tetu, B., and Dube, J. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors. Am. J. Pathol., 150: 455-459, 1997.
11. Charlesworth, M., Young, C., Klee, G., Saedi, M., Mikolajczyk, S., Finlay, J., and Tindall, D. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology, 49: 487-493, 1997.
12. Darson, M., Pacelli, A., Roche, P., Rittenhouse, H., Wolfert, R., Young, C., Klee, G., Tindall, D., and Bostwick, D. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology, 49: 857-852, 1997.
13. Frenette, G., Tremblay, R., Lazure, C. and Dube, J. Prostate kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator. Int. J. Cancer, 71: 897-899, 1997.
14. Kumar, A., Mikolajczyk, S., Goel, A., Millar, L., and Saedi, M. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res., 57: 3111-3114, 1997.
15. Lovgren, J., Rajakoski, K., Karp, M., Lundwall, A., and Lilja, H. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Biophys. Res. Commun., 238: 549-555, 1997.
16. Takayama, T., Fujikawa, K., and Davie, E. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem., 272: 21582-21588, 1997.
17. Murtha, P., Tindall, D., and Young, C. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry, 32: 6459-6464, 1993.
18. Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., and Henderson, D. R. Prostate-specific antigen expression in regulated by an upstream enhancer. J. Biol Chem., 271: 7043-7051, 1996.
19. Cleutjens, K., van Eekelen, C., van der Korput, H., Brinkmann, A., and Trapman, J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem., 271: 6379-6388, 1996.
20. Cleutjens, K. B., van der Korput, H. A., van Eekelen, C. C., van Rooji, H. C., Faber, P. W., and Trapman, J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol., 11: 148-161, 1997.
21. Pang, S., Dannull, J., Kaboo, R., Xie, Y., Tso, C., Michel, K., Dekernion, J., and Belldegrun, A. Identification of a positive regulatory elements responsible for tissue-specific expression of prostate-specific antigen. Cancer Res., 57: 495-499, 1997.
22. Bett, A. J., Haddara, W., Prevec, L., and Graham, F. L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA, 91: 8802-8806, 1994.
23. Rodriguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., and Henderson, D. R. Prostate-attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen positive prostate cancer cells. Cancer Res., 57: 2559-2563, 1997.
24. Goodrum, F. D., and Ornelles, D. A. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic cycle. J Virol., 72: 9479-9490, 1998.
25. Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., and Hausen, H. Z. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol., 72: 9470-9478, 1998.
26. Beato, M. Gene regulation by steroid hormones. Cell, 56: 335-344, 1989.
27. Grino, P. B., Griffen, J. E., and Wilson, J. D. Androgen resistance due to decreased amounts of androgen receptor: a reinvestigation. J. Steroid Biochem., 35: 647-654, 1990.
28. Culig, Z., Hobisch, A., Hittmair, A., Peterziel, H., Cato, A., Barsch, G., and Klocker, H. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate, 35: 63-70, 1998.
29. Chang, C. S., Kokontis, J., and Liao, S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc. Natl. Acad. Sci. USA, 85: 7211-7215, 1988.
30. Young, C., Andrews, P., Montgomery, B., and Tindall, D. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry, 31: 818-824, 1992.
31. Qui, S., Young, C., Bilhartz, D., Prescott, J., Farrow, G., He, W., and Tindall, D. In situ hybridization of prostate-specific antigen mRNA in human prostate. J. Urol., 144: 1550-1556, 1990.
32. Wolf, D., Schulz, P., and Fittler, F. Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol. Endocrinol., 6: 753-762, 1992.
33. Diamandis, E. P., Yu, H., and Lopez-Otin, C. Prostate specific antigen: a new constituent of breast cyst fluid. Breast Cancer Res. Treat., 38: 259-264, 1996.
34. Hsieh, M. L., Charlesworth, M. C., Goodmanson, M., Zhang, S., Seay, T., Klee, G. G., Tindall, D. J., and Young, C. Y. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res., 57: 2651-2656, 1997.
35. Young, C., Montgomery, B., Andrews, P., Qui, S., Bilhartz, D., and Tindall, D. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
36. Hsieh, J. T., Wu, H. C., Gleave, M. E., von Eschenbach, A. C., and Chung, L. E. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic (LNCaP) subline. Cancer Res., 53: 2852-2857, 1993.
37. Karr, J. F., Kantor, J. A., Hand, P. H., Eggensperger, D. L., and Schlom, J. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res., 55: 2455-2462, 1995.